Lin Yang

Associate

Hong Kong

+ 852 2241 2575

Email
vcard

Areas of Work

Anti-Corruption/FCPA, Independent & Internal Investigations, Commercial Trials & Litigation, International Arbitration

Languages

Mandarin Chinese

Cantonese

Overview

Lin Yang is a highly experienced attorney with a strong focus on international regulatory compliance, cross‑border investigations, and complex litigation involving multinational corporations. She has significant experience representing major global companies in high‑profile US criminal matters and related civil proceedings, including multi‑year, multi‑jurisdictional cases requiring close coordination across US and China‑based teams. Her work frequently involves sensitive cross‑border evidence issues, internal investigations, and advising on enforcement risks associated with operations in China and Southeast Asia.

Lin regularly advises clients on compliance with the Foreign Corrupt Practices Act (FCPA), US securities laws, internal controls, and third‑party risk management. She conducts internal investigations, leads compliance assessments and audits of Sino‑foreign joint ventures, and provides remediation guidance on issues involving books and records, improper payments, and high‑risk business practices.

Recognized in the market for her cross‑border investigations, litigation, and regulatory compliance practice, Lin was named as one of the Hong Kong Rising Stars by Asian Legal Business in 2024. Her combined understanding of US enforcement expectations and the regulatory landscape in China positions her as a trusted advisor to multinational corporations navigating complex global compliance, investigative, and litigation matters.

District of Columbia
New York
PRC Non-practicing license
Registered Foreign Lawyer, Hong Kong

J.D., George Mason University School of Law
B.A., Sun Yat-Sen University School of Law

Representative Matters

Represented leading Chinese companies in multi‑year criminal and civil proceedings in US federal courts.
Advised a major Chinese technology company in high‑stakes patent litigation spanning multiple forums.
Defended leading Chinese companies in complex trade secret litigation before US federal courts.
Defended multinational nutrition and chemical companies in US federal patent litigation.
Conducted a FCPA internal investigation for a leading global engineering and logistics company.
Conducted third party due diligence reviews for more than 40 resellers/agents in Mainland China.
Assisted a leading international accounting firm with preparation of expert witness evidence on compliance with PRC State Secrets Law and directives issued by the relevant supervising government organ.
Represented a Chinese manufacturer in commercial litigation in Washington state court and federal court, successfully defeated adverse party’s motion to dismiss certain claims.
Conducted a proactive compliance audit of Sino-foreign joint venture and its distributors on behalf of a large US pharmaceutical company.
Represented a large US pharmaceutical company in relation to a number of FCPA internal investigations across various cities in China, including issues related to trusts and estates, inaccurate books and records, improper payments to health care professionals, and high risk third-party transactions.
Represented a global hospitality business in relation to a number of FCPA, fraud, and immigration law related internal investigations in Malaysia.
Conducted internal investigations for one of the largest MNC pharmaceutical companies in response to the DOJ's inquiry regarding certain FCPA issues related to its sales practices.